down arrow

Renhe Pharmacy Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000NF8
CNY
6.02
-0.02 (-0.33%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Renhe Pharmacy Co., Ltd.
Why is Renhe Pharmacy Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -2.05% and Operating profit at -6.81% over the last 5 years
2
The company has declared Negative results for the last 3 consecutive quarters
  • NET SALES(HY) At CNY 1,888.99 MM has Grown at -22.15%
  • OPERATING CASH FLOW(Y) Lowest at CNY 655.1 MM
  • NET PROFIT(9M) At CNY 299.28 MM has Grown at -25.08%
3
With ROE of 7.97%, it has a attractive valuation with a 1.24 Price to Book Value
  • Over the past year, while the stock has generated a return of 4.64%, its profits have fallen by -16.6%
  • At the current price, the company has a high dividend yield of 2.4
4
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
5
Underperformed the market in the last 1 year
  • The stock has generated a return of 4.64% in the last 1 year, much lower than market (China Shanghai Composite) returns of 15.18%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Renhe Pharmacy Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Renhe Pharmacy Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Renhe Pharmacy Co., Ltd.
1.52%
-0.18
24.41%
China Shanghai Composite
15.19%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-2.05%
EBIT Growth (5y)
-6.81%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
0.74
Tax Ratio
26.90%
Dividend Payout Ratio
43.09%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.78%
ROE (avg)
11.84%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.24
EV to EBIT
8.65
EV to EBITDA
6.84
EV to Capital Employed
1.56
EV to Sales
1.15
PEG Ratio
NA
Dividend Yield
2.39%
ROCE (Latest)
18.01%
ROE (Latest)
7.97%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -4.12% (YoY

CASH AND EQV(HY)

Highest at CNY 7,568.99 MM

DEBT-EQUITY RATIO (HY)

Lowest at -60.47 %

-14What is not working for the Company
NET SALES(HY)

At CNY 1,888.99 MM has Grown at -22.15%

OPERATING CASH FLOW(Y)

Lowest at CNY 655.1 MM

NET PROFIT(9M)

At CNY 299.28 MM has Grown at -25.08%

DEBTORS TURNOVER RATIO(HY)

Lowest at 5%

Here's what is working for Renhe Pharmacy Co., Ltd.
Cash and Eqv
Highest at CNY 7,568.99 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at -60.47 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -4.12% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Renhe Pharmacy Co., Ltd.
Net Sales
At CNY 1,888.99 MM has Grown at -22.15%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Operating Cash Flow
Lowest at CNY 655.1 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Profit
At CNY 299.28 MM has Grown at -25.08%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

Debtors Turnover Ratio
Lowest at 5%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."